Clinical trial
Valsartan Optimal Therapy Against Elevated Home Blood Pressure…
NCT00460213 · Kitakyushu-Tsuyazaki Hospital, Other · Completed
Key facts
| NCT number | NCT00460213 |
|---|---|
| Title | Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study |
| Official title | Study on Optimal Anti-hypertensive Therapy With Valsartan by Using Home Blood Pressure Measurement |
| Lead sponsor | Kitakyushu-Tsuyazaki Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Valsartan 80mg daily, Valsartan 160mg daily |
| Enrollment | 103 |
| Start date | Jul 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Nov 1, 2013 |
| First posted | Apr 13, 2007 |
| Last update posted | Dec 9, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: